These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 10446763)

  • 1. Effect of the 5-hydroxytryptamine3 (5-HT3)-receptor antagonist KB-R6933 on experimental diarrhea models.
    Ozaki A; Yoshidomi M; Sukamoto T
    Jpn J Pharmacol; 1999 May; 80(1):93-6. PubMed ID: 10446763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective 5-hydroxytryptamine3 (5-HT3) receptor blocking activity of KB-R6933, a novel benzimidazole derivative.
    Ozaki A; Fujishima Y; Sukamoto T
    Jpn J Pharmacol; 1999 May; 80(1):25-32. PubMed ID: 10446753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement of cisplatin-induced emesis and delayed gastric emptying by KB-R6933, a novel 5-HT3 receptor antagonist.
    Ozaki A; Sukamoto T
    Gen Pharmacol; 1999 Sep; 33(3):283-8. PubMed ID: 10480662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antidiarrheal activity of cashew GUM, a complex heteropolysaccharide extracted from exudate of Anacardium occidentale L. in rodents.
    Araújo TS; Costa DS; Sousa NA; Souza LK; de Araújo S; Oliveira AP; Sousa FB; Silva DA; Barbosa AL; Leite JR; Medeiros JV
    J Ethnopharmacol; 2015 Nov; 174():299-307. PubMed ID: 26297843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the pharmacological profile of ramosetron, a novel therapeutic agent for irritable bowel syndrome.
    Hirata T; Keto Y; Funatsu T; Akuzawa S; Sasamata M
    J Pharmacol Sci; 2007 Jul; 104(3):263-73. PubMed ID: 17652911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The involvement of 5-HT3 and 5-HT4 receptors in two models of gastrointestinal transit in mice.
    Pascual D; Alsasua A; Goicoechea C; Martín MI
    Neurosci Lett; 2002 Jul; 326(3):163-6. PubMed ID: 12095647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of serotonin 5-HT3 receptor antagonists on stress-induced colonic hyperalgesia and diarrhoea in rats: a comparative study with opioid receptor agonists, a muscarinic receptor antagonist and a synthetic polymer.
    Hirata T; Keto Y; Nakata M; Takeuchi A; Funatsu T; Akuzawa S; Sasamata M; Miyata K
    Neurogastroenterol Motil; 2008 May; 20(5):557-65. PubMed ID: 18221252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of KW-5617 (zaldaride maleate), a potent and selective calmodulin inhibitor, on secretory diarrhea and on gastrointestinal propulsion in rats.
    Aikawa N; Karasawa A
    Jpn J Pharmacol; 1998 Feb; 76(2):199-206. PubMed ID: 9541283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the effects of trimebutine and YM114 (KAE-393), a novel 5-HT3 receptor antagonist, on stress-induced defecation.
    Miyata K; Ito H; Yamano M; Hidaka K; Kamato T; Nishida A; Yuki H
    Eur J Pharmacol; 1993 Dec; 250(2):303-10. PubMed ID: 8112388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotonin 5-HT3 receptor antagonist for treatment of severe diabetic diarrhea.
    Murao S; Hosokawa H
    Diabetes Care; 2010 Mar; 33(3):e38. PubMed ID: 20190286
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibitory effects of ramosetron, a potent and selective 5-HT3-receptor antagonist, on conditioned fear stress-induced abnormal defecation and normal defecation in rats: comparative studies with antidiarrheal and spasmolytic agents.
    Hirata T; Funatsu T; Keto Y; Akuzawa S; Sasamata M; Miyata K
    J Pharmacol Sci; 2008 Feb; 106(2):264-70. PubMed ID: 18296863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-HT2 and 5-HT3 receptor subtypes mediate cholera toxin-induced intestinal fluid secretion in the rat.
    Beubler E; Horina G
    Gastroenterology; 1990 Jul; 99(1):83-9. PubMed ID: 2344945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antidiarrhoeal activity of aqueous leaf extract of Caladium bicolor (Araceae) and its possible mechanisms of action.
    Salako OA; Akindele AJ; Shitta OM; Elegunde OO; Adeyemi OO
    J Ethnopharmacol; 2015 Dec; 176():225-31. PubMed ID: 26514064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological profile of ramosetron, a novel therapeutic agent for IBS.
    Hirata T; Funatsu T; Keto Y; Nakata M; Sasamata M
    Inflammopharmacology; 2007 Feb; 15(1):5-9. PubMed ID: 17323187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of serotonin 5-HT(3) receptor antagonists on CRF-induced abnormal colonic water transport and defecation in rats.
    Hirata T; Keto Y; Nakata M; Takeuchi A; Funatsu T; Akuzawa S; Sasamata M; Miyata K
    Eur J Pharmacol; 2008 Jun; 587(1-3):281-4. PubMed ID: 18456254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacological studies of loperamide, an anti-diarrheal agent. I. Effects on diarrhea induced by castor oil and prostaglandin E. (author's transl)].
    Sohji Y; Kawashima K; Nakamura H; Shimizu M
    Nihon Yakurigaku Zasshi; 1978 Jan; 74(1):145-54. PubMed ID: 25231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of FK1052, a potent 5-hydroxytryptamine3 and 5-hydroxytryptamine4 receptor dual antagonist, on colonic function in vivo.
    Kadowaki M; Nagakura Y; Tomoi M; Mori J; Kohsaka M
    J Pharmacol Exp Ther; 1993 Jul; 266(1):74-80. PubMed ID: 8331576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enzyme immunoassay for 6-amino-5-chloro-1-isopropyl-2-(4-methyl-1-piperazinyl)benzimidazole, a novel 5-HT3 receptor antagonist.
    Fujikawa M; Teratani F; Nakada Y
    Biol Pharm Bull; 2001 Apr; 24(4):422-4. PubMed ID: 11305607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined blockade of 5-HT3- and 5-HT4-serotonin receptors inhibits colonic functions in conscious rats and mice.
    Nagakura Y; Kontoh A; Tokita K; Tomoi M; Shimomura K; Kadowaki M
    J Pharmacol Exp Ther; 1997 Apr; 281(1):284-90. PubMed ID: 9103508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antidiarrheal activity of α-terpineol in mice.
    Dos Santos Negreiros P; da Costa DS; da Silva VG; de Carvalho Lima IB; Nunes DB; de Melo Sousa FB; de Souza Lopes Araújo T; Medeiros JVR; Dos Santos RF; de Cássia Meneses Oliveira R
    Biomed Pharmacother; 2019 Feb; 110():631-640. PubMed ID: 30540974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.